Innovation Pharmaceuticals Inc (IPIX)

[ericseb2003]

Cabel, the market will likely respond with EXPONENTIALLY more confidence once the more granular bottom-line results from the PIIB trial for Brilacidin are released in the next 3 to 4 weeks. Top-line results are promising, and the 100%+ bounce off the lows put in earlier this year are a testament to that, however, a more powerful and enduring reaction will depend on the release of definitive and unequivocal proof of success for the 1 or 3-day arms.